Ophthalmology
1 drug is in development for Glaucoma.
- Companies
- 1
- Clinical trials
- 15
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Glaucoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| bim-drs | SpyGlass Pharma Inc. (SGP) |
About this indication
Glaucoma context
Ophthalmology·MeSH: Glaucoma (D005901)
Also known as: Glaucomas
Prevalence
3000.0 / 100K
Incidence
150.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Glaucoma?
BioSniper tracks 1 drug in development for Glaucoma across 1 company.
How many clinical trials target Glaucoma?
There are 15 clinical trials targeting Glaucoma tracked by BioSniper.
What is the prevalence of Glaucoma?
The estimated prevalence of Glaucoma is approximately 3000.0 per 100,000 population.